AMED - Amedisys, Inc.
121.92 0.00 (0.00%)
After hours: 4:00PM EDT
| Previous Close | 123.07 |
| Open | 122.66 |
| Bid | 121.93 x 900 |
| Ask | 121.99 x 800 |
| Day's Range | 120.89 - 123.01 |
| 52 Week Range | 83.78 - 140.91 |
| Volume | 241,218 |
| Avg. Volume | 433,020 |
| Market Cap | 3.907B |
| Beta (3Y Monthly) | 1.34 |
| PE Ratio (TTM) | 32.83 |
| EPS (TTM) | 3.71 |
| Earnings Date | Jul 29, 2019 - Aug 2, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 136.00 |
- Zacks•7 hours ago
Amedisys (AMED) Upgraded to Strong Buy: Here's What You Should Know
Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
- Zacks•3 days ago
Top Ranked Momentum Stocks to Buy for June 21st
Top Ranked Momentum Stocks to Buy for June 21st
- Zacks•3 days ago
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR
Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR
- Zacks•4 days ago
Bet Big on DuPont Analysis With These Top 5 Picks
Do you have more faith in DuPont analysis than a simple ROE calculation? Bet on these five stocks then.
- Insider Monkey•5 days ago
Here’s What Hedge Funds Think About Amedisys Inc (AMED)
We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st. In this article, we look at what those funds think of Amedisys Inc (NASDAQ:AMED) based on that data. […]
- Zacks•7 days ago
Here is Why Growth Investors Should Buy Amedisys (AMED) Now
Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks•10 days ago
Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos
Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos
- Simply Wall St.•10 days ago
I Ran A Stock Scan For Earnings Growth And Amedisys (NASDAQ:AMED) Passed With Ease
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
- Zacks•11 days ago
5 Stocks With Impressive Interest Coverage Ratio to Buy Now
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
- Markit•13 days ago
See what the IHS Markit Score report has to say about Amedisys Inc.
Amedisys Inc NASDAQ/NGS:AMEDView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold AMED had net inflows of $1.01 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Investor's Business Daily•19 days ago
Why You Should Keep An Eye On These Leading Health Care Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- Zacks•24 days ago
Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR
Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR
- Zacks•24 days ago
3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED)
Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks•25 days ago
Amedisys (AMED) Down 9.3% Since Last Earnings Report: Can It Rebound?
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•25 days ago
Is Trade War Scaring You? Buy 5 DuPont-Tested Quality Stocks
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
- GlobeNewswire•26 days ago
Amedisys to Present at the William Blair 2019 Growth Stock Conference
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the William Blair 2019 Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
- GlobeNewswire•last month
Amedisys to Present at the Jefferies 2019 Healthcare Conference
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference in New York City, NY on Tuesday, June 4, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
- Simply Wall St.•last month
Do Directors Own Amedisys, Inc. (NASDAQ:AMED) Shares?
The big shareholder groups in Amedisys, Inc. (NASDAQ:AMED) have power over the company. Large companies usually have...
- GlobeNewswire•last month
Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 RBC Capital Markets Healthcare Conference in New York City, NY on Tuesday, May 21, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
- Zacks•2 months ago
Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems
Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems
- GlobeNewswire•2 months ago
Media Statement from Amedisys Commending the Home Health Payment Innovation Act of 2019
BATON ROUGE, La., May 08, 2019 -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation.
- GlobeNewswire•2 months ago
Amedisys to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2019. Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care.
